Green Cross have published a series of biarylpyrazolyl oxadiazole based compounds as CB1 antagonists… more →
GPCR Newscannabis-seeds wrote 2 months ago: Just thought we’d share some helpful tips on what NOT to do when growing cannabis: 1. Don´t Ov … more →
cbdresearch wrote 3 months ago: Raphael Mechoulam (according to Wikipedia) is professor of Medicinal Chemistry and Natural Products … more →
cannabis-seeds wrote 4 months ago: On the surface, it stands to reason that people who smoke cannabis could possibly face similar eleva … more →
sakerfa wrote 6 months ago: On June 11, 2009, federal judge George Wu sentenced California resident, Charlie Lynch, to one year … more →
marijuanacannabis wrote 6 months ago: This just shows how much of a fraud the whole prohabition of cannabis is. The US Government’s … more →
crimsoncanary wrote 1 year ago: Green Cross have published a series of biarylpyrazolyl oxadiazole based compounds as CB1 antagonists … more →
crimsoncanary wrote 1 year ago: KeyNeurotek Pharmaceuticals have received Orphan Drug Designation for its lead cannabinoid agonist c … more →
valmax83 wrote 1 year ago: Massachusetts — The mounting uses of medicinal marijuana got higher after researchers found co … more →
crimsoncanary wrote 1 year ago: Researchers at he University of Texas have published a series of cannabinoid receptor 2 (CB2) agonis … more →
highboldtage wrote 1 year ago: Can Cannabis Compounds Slow The Progression Of Multiple Sclerosis? ScienceDaily (July 21, 2008) — Th … more →
crimsoncanary wrote 1 year ago: Glenmark Pharmaceuticals have announced that its CB2 agonist GRC-10693 is entering Phase I trials fo … more →
marijuanacannabis wrote 1 year ago: Anti-obesity drugs that work by blocking brain molecules similar to those in marijuana could also in … more →
marijuanacannabis wrote 1 year ago: A cannabis like substance produced by the brain may dampen delusional or psychotic experiences, rath … more →
marijuanacannabis wrote 1 year ago: An old solution for new problems. The qualities that made cannabis one of our ancestors’ most useful … more →
crimsoncanary wrote 1 year ago: Watson have announced the launch of generic dronabinol under a supply agreement with Solvay Pharmace … more →
crimsoncanary wrote 1 year ago: Pfizer are about to begin a Phase I study of Cannabinoid 1 antagonist CP-945598 In Patients With Non … more →
crimsoncanary wrote 1 year ago: Data presented at EULAR show that treatment of fibroblasts from systemic sclerosis patients with a c … more →
crimsoncanary wrote 1 year ago: Clinical data presented at ADA show Sanofi-aventis’ CB1 antagonist rimonabant significantly im … more →
crimsoncanary wrote 1 year ago: Phase I results of KeyNeurotek’s cannabinoid receptor agonist KN38-7271 show all study endpoin … more →